MONTRÉAL, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company”), a leading Canadian Healthtech company,…
Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural…
January 26, 2026 17:00 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…
January 23, 2026 17:25 ET | Source: Immunovant Inc. DURHAM, N.C. and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) --…
MUMBAI, India, Jan. 23, 2026 /PRNewswire/ -- STL (NSE: STLTECH), a leading connectivity solutions provider for AI-ready digital infrastructure, today…
January 22, 2026 16:05 ET | Source: Adaptive Biotechnologies SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:…
PERFORMANCE FOR THE QUARTER ENDED DECEMBER 31, 2025Individual weighted premium income of ₹ 1,915.3 crore with a year-on-year growth of…
Results demonstrate a favorable safety profile and functional improvements in patients with severe tricuspid regurgitation including patients with reduced right…
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 21, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in premier…
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and…